CEACAM1 was reported to enhance apoptosis in cancer cells via a mitochondrial death pathway involving increased activity of caspases 3, 6, and 9, reduced expression of Bcl-2, mitochondrial translocation of Bax, and an increase of cytosolic apoptosis-inducing factor18. This evidence concerns the gene BCL2 and cancer.